Literature DB >> 17969558

Genetically engineered stem cells for therapeutic gene delivery.

Claudius Conrad1, Rashmi Gupta, Hema Mohan, Hanno Niess, Christiane J Bruns, Reinhard Kopp, Irene von Luettichau, Markus Guba, Christopher Heeschen, Karl-Walter Jauch, Ralf Huss, Peter J Nelson.   

Abstract

Stem cell and gene therapy approaches have held out much hope for the development of new tools to treat disease. Therapeutic approaches based on these methods have only rarely found their way into the clinic. The linking of stem cell therapy with selective gene therapy enhances therapeutic options for the regeneration or replacement of diseased or missing cells. This review focuses on the rationale and preliminary results of combining stem cell and gene therapy. Special emphasis is placed on various molecular techniques currently used to genetically engineer stem cells. Viral and nonviral genes delivering technologies are detailed as are techniques for the modulation of gene expression in the context of stem cell recruitment and differentiation. Finally potential clinical applications for this new therapeutic strategy are discussed.

Mesh:

Substances:

Year:  2007        PMID: 17969558     DOI: 10.2174/156652307781369119

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  13 in total

1.  Mesenchymal stem cells in regenerative medicine: of hopes and challenges.

Authors:  Claudius Conrad
Journal:  Medscape J Med       Date:  2009-01-28

2.  Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury.

Authors:  Anne-Laure Leblond; Patrice Naud; Virginie Forest; Clothilde Gourden; Christine Sagan; Bénédicte Romefort; Eva Mathieu; Bruno Delorme; Christine Collin; Jean-Christophe Pagès; Luc Sensebé; Bruno Pitard; Patricia Lemarchand
Journal:  Hum Gene Ther       Date:  2009-11       Impact factor: 5.695

3.  An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells.

Authors:  Jae-Hyung Jang; James T Koerber; Jung-Suk Kim; Prashanth Asuri; Tandis Vazin; Melissa Bartel; Albert Keung; Inchan Kwon; Kook In Park; David V Schaffer
Journal:  Mol Ther       Date:  2011-01-11       Impact factor: 11.454

4.  Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells.

Authors:  Prashanth Asuri; Melissa A Bartel; Tandis Vazin; Jae-Hyung Jang; Tiffany B Wong; David V Schaffer
Journal:  Mol Ther       Date:  2011-11-22       Impact factor: 11.454

5.  DNA aptamer-mediated cell targeting.

Authors:  Xiangling Xiong; Haipeng Liu; Zilong Zhao; Meghan B Altman; Dalia Lopez-Colon; Chaoyong James Yang; Lung-Ji Chang; Chen Liu; Weihong Tan
Journal:  Angew Chem Int Ed Engl       Date:  2012-12-11       Impact factor: 15.336

6.  Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery.

Authors:  Kerstin Knoop; Marie Kolokythas; Kathrin Klutz; Michael J Willhauck; Nathalie Wunderlich; Dan Draganovici; Christian Zach; Franz-Josef Gildehaus; Guido Böning; Burkhard Göke; Ernst Wagner; Peter J Nelson; Christine Spitzweg
Journal:  Mol Ther       Date:  2011-05-17       Impact factor: 11.454

7.  Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.

Authors:  Kerstin Knoop; Nathalie Schwenk; Patrick Dolp; Michael J Willhauck; Christoph Zischek; Christian Zach; Markus Hacker; Burkhard Göke; Ernst Wagner; Peter J Nelson; Christine Spitzweg
Journal:  Hum Gene Ther       Date:  2013-03       Impact factor: 5.695

8.  Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models.

Authors:  Bo-Rim Yi; Min-Ah Park; Hye-Rim Lee; Nam-Hee Kang; Kelvin J Choi; Seung U Kim; Kyung-Chul Choi
Journal:  Mol Oncol       Date:  2013-01-19       Impact factor: 6.603

9.  Gene delivery to human adult and embryonic cell-derived stem cells using biodegradable nanoparticulate polymeric vectors.

Authors:  F Yang; J J Green; T Dinio; L Keung; S-W Cho; H Park; R Langer; D G Anderson
Journal:  Gene Ther       Date:  2009-01-08       Impact factor: 5.250

10.  Amelioration of emphysema in mice through lentiviral transduction of long-lived pulmonary alveolar macrophages.

Authors:  Andrew A Wilson; George J Murphy; Hiroshi Hamakawa; Letty W Kwok; Sreedevi Srinivasan; Avi-Hai Hovav; Richard C Mulligan; Salomon Amar; Bela Suki; Darrell N Kotton
Journal:  J Clin Invest       Date:  2009-12-21       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.